Ourui One Wart Complete Care Kit Corn Wart Remover, Ourui One Wart Complete C...

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common warts and plantar warts. Common warts are characterized by a rough, "cauliflower-like" surface and are easily recognizable. Plantar warts are specifically located on the soles of the feet, are tender to touch, and exhibit an interrupted footprint pattern.

No teratogenic or nonteratogenic effects have been reported.

Dosage and Administration

The affected area should be washed thoroughly, and soaking the wart in warm water for approximately 5 minutes may enhance the effectiveness of the treatment. After washing, the area must be dried completely.

For the Corn & Wart Remover, a sufficient amount of the product should be applied using a cotton swab to ensure complete coverage of each wart. It is essential to allow the application to dry. This procedure may be repeated once or twice daily as needed, continuing until the wart is removed, but not exceeding a duration of 12 weeks.

For the Wart Remover Cream, the same initial steps apply: wash the affected area and, if desired, soak in warm water for 5 minutes before drying thoroughly. A small amount of cream should then be applied to cover each wart, followed by allowing it to dry. This application should be repeated twice daily as needed, for a maximum duration of 12 weeks.

Contraindications

Use of CORN & WART REMOVER and WART REMOVER CREAM is contraindicated in the following situations:

• Application on irritated skin, infected areas, or any reddened skin is prohibited due to the potential for exacerbating irritation or infection.

• The products should not be used on moles, birthmarks, warts with hair growth, genital warts, or warts located on the face or mucous membranes, as these conditions may lead to adverse effects or complications.

• Patients with diabetes or poor blood circulation should avoid these products, as they may increase the risk of serious complications in these populations.

Warnings and Precautions

For external use only, both the Corn & Wart Remover and Wart Remover Cream must be handled with care. These products should be kept away from fire and flame to prevent any hazardous incidents.

Contact with the eyes must be strictly avoided. In the event that either product comes into contact with the eyes, it is imperative to rinse thoroughly with water for at least 15 minutes. Both formulations are non-edible; therefore, they should be stored securely, with the cap tightly closed, at room temperature and away from heat sources.

Healthcare professionals should advise patients who are pregnant or breastfeeding to consult with a health professional prior to using the Wart Remover Cream to ensure safety during these sensitive periods.

In case of accidental ingestion, immediate medical assistance is required. Patients should be instructed to contact a Poison Control Center at 1-800-222-1222 or seek emergency medical help without delay.

Patients should discontinue use of either product and consult a healthcare provider if discomfort persists, as this may indicate a need for further evaluation or alternative treatment options.

Side Effects

Patients using the Corn & Wart Remover and Wart Remover Cream should be aware of specific warnings and recommendations regarding their use. Both products are intended for external use only and should be kept away from fire and flame. It is crucial to avoid contact with the eyes; in the event of contact, patients should rinse the eyes with water for 15 minutes. Additionally, inhalation of vapors should be avoided.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if discomfort persists after application of either product. This recommendation applies to both the Corn & Wart Remover and the Wart Remover Cream, ensuring that any ongoing discomfort is appropriately evaluated by a doctor.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Ourui One Wart Complete Care Kit Corn Wart Remover, Ourui One Wart Complete Care Kit Wart Remover (salicylic acid 17% wart complete care kit corn wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted.

This product is contraindicated for use on irritated skin or any area that is infected or reddened. It should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Additionally, it is not recommended for use in individuals with diabetes or poor blood circulation.

For pregnant or breastfeeding patients, consultation with a healthcare professional is advised prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is essential to evaluate the potential risks and benefits associated with its use during pregnancy and lactation. Healthcare providers should consider the available data and individual patient circumstances when advising on the use of this medication in these populations.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data necessitates careful evaluation of potential risks and benefits.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or toxicology expert may also be beneficial in managing the case effectively.

It is crucial to document all findings and interventions thoroughly, as this information may be vital for ongoing patient management and for any necessary reporting to regulatory authorities.

Nonclinical Toxicology

No relevant information is available regarding teratogenic or non-teratogenic effects. Additionally, there are no findings related to nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact the Poison Control Center at 1-800-222-1222 if the product is swallowed. It is crucial to emphasize the importance of prompt action in such situations.

Patients should be informed to avoid contact with the eyes. In the event of accidental exposure, they should flush the eye with water for at least 15 minutes and seek medical attention if irritation persists. Additionally, patients should be reminded that the product is non-edible and should be stored securely, with the cap tightly closed, at room temperature and away from heat sources.

For patients who are pregnant or breastfeeding, it is essential to recommend consulting a healthcare professional prior to using the product to ensure safety for both the patient and the child.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that it is kept away from excessive heat, defined as temperatures exceeding 37°C (99°F). Proper storage conditions are crucial to maintain the integrity and efficacy of the product.

Additional Clinical Information

Patients who are pregnant or breastfeeding should consult a health professional prior to use. No further information is available regarding laboratory tests, abuse potential, route, method, or frequency of administration, as well as postmarketing experience.